Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-084325
Filing Date
2025-04-17
Accepted
2025-04-17 16:10:58
Documents
21
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A d921496dpre14a.htm   iXBRL PRE 14A 742505
3 GRAPHIC g921496g01a01.jpg GRAPHIC 37467
4 GRAPHIC g921496g01g01.jpg GRAPHIC 284052
5 GRAPHIC g921496g02g02.jpg GRAPHIC 232767
6 GRAPHIC g921496g06a06.jpg GRAPHIC 55920
7 GRAPHIC g921496g13j07.jpg GRAPHIC 17377
8 GRAPHIC g921496g51w01.jpg GRAPHIC 53138
9 GRAPHIC g921496g73l41.jpg GRAPHIC 60831
10 GRAPHIC g921496g90t91.jpg GRAPHIC 23079
  Complete submission text file 0001193125-25-084325.txt   2870599

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20241231.xsd EX-101.SCH 2498
23 EXTRACTED XBRL INSTANCE DOCUMENT d921496dpre14a_htm.xml XML 3799
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39659 | Film No.: 25847416
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)